Griesdale Donald E G
Crit Care. 2012 Dec 27;16(6):189. doi: 10.1186/cc11889.
Etomidate is an intravenous induction agent that is associated with hemodynamic stability during intubation. The agent is therefore attractive for use in critically ill patients who have a high risk of hemodynamic instability during this procedure. However, etomidate causes adrenal suppression, which itself has been associated with increased mortality in critically ill patients. The ongoing debate surrounding use of etomidate is thus centered on the immediate favorable hemodynamic profile versus the long-term risks of adrenal insufficiency, particularly in patients who have severe sepsis or septic shock.
依托咪酯是一种静脉诱导剂,在插管过程中与血流动力学稳定性相关。因此,该药物对于在此过程中存在血流动力学不稳定高风险的重症患者具有吸引力。然而,依托咪酯会导致肾上腺抑制,而这本身与重症患者死亡率增加有关。因此,围绕依托咪酯使用的持续争论集中在其即时有利的血流动力学特征与肾上腺功能不全的长期风险之间,尤其是在患有严重脓毒症或脓毒性休克的患者中。